Terms: = Breast cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Treatment
86 results:
1. Clinical characteristics, proteins, and genes related to interstitial pneumonia-associated squamous cell carcinoma of the lungs.
Mochizuki A; Nishida H; Kaimori R; Kondo Y; Kadowaki H; Kusaba T; Kawamura K; Osoegawa A; Sugio K; Daa T
Pathol Res Pract; 2024 May; 257():155292. PubMed ID: 38657559
[TBL] [Abstract] [Full Text] [Related]
2. Highly proliferative and hypodifferentiated CAR-T cells targeting B7-H3 enhance antitumor activity against ovarian and triple-negative breast cancers.
Zhang X; Guo H; Chen J; Xu C; Wang L; Ke Y; Gao Y; Zhang B; Zhu J
Cancer Lett; 2023 Sep; 572():216355. PubMed ID: 37597651
[TBL] [Abstract] [Full Text] [Related]
3. stat5 inhibits NLRP3-mediated pyroptosis to enhance chemoresistance of breast cancer cells via promoting miR-182 transcription.
Wan P; He X; Han Y; Wang L; Yuan Z
Chem Biol Drug Des; 2023 Jul; 102(1):14-25. PubMed ID: 36905318
[TBL] [Abstract] [Full Text] [Related]
4. Immunomodulatory Role of Diospyros peregrina Fruit Preparation in breast cancer by Utilizing Macrophage Mediated Antigen Presentation and T Helper Cell (Th) Differentiation.
Mahalakshmi Surendran A; Rai A; Rakshit S; George M; Sarkar K
Clin Breast Cancer; 2023 Apr; 23(3):e95-e102. PubMed ID: 36641322
[TBL] [Abstract] [Full Text] [Related]
5. Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/stat5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell line.
Guvenir Celik E; Eroglu O
Mol Biol Rep; 2023 Jan; 50(1):319-329. PubMed ID: 36331743
[TBL] [Abstract] [Full Text] [Related]
6. STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
Wong GL; Manore SG; Doheny DL; Lo HW
Semin Cancer Biol; 2022 Nov; 86(Pt 3):84-106. PubMed ID: 35995341
[TBL] [Abstract] [Full Text] [Related]
7. Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivo.
Yue P; Zhu Y; Brotherton-Pleiss C; Fu W; Verma N; Chen J; Nakamura K; Chen W; Chen Y; Alonso-Valenteen F; Mikhael S; Medina-Kauwe L; Kershaw KM; Celeridad M; Pan S; Limpert AS; Sheffler DJ; Cosford NDP; Shiao SL; Tius MA; Lopez-Tapia F; Turkson J
Cancer Lett; 2022 May; 534():215613. PubMed ID: 35276290
[TBL] [Abstract] [Full Text] [Related]
8. MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early-stage breast cancer patients.
Haan JC; Bhaskaran R; Ellappalayam A; Bijl Y; Griffioen CJ; Lujinovic E; Audeh WM; Penault-Llorca F; Mittempergher L; Glas AM
Genes Chromosomes Cancer; 2022 Mar; 61(3):148-160. PubMed ID: 34841595
[TBL] [Abstract] [Full Text] [Related]
9. Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.
Liang HC; Costanza M; Prutsch N; Zimmerman MW; Gurnhofer E; Montes-Mojarro IA; Abraham BJ; Prokoph N; Stoiber S; Tangermann S; Lobello C; Oppelt J; Anagnostopoulos I; Hielscher T; Pervez S; Klapper W; Zammarchi F; Silva DA; Garcia KC; Baker D; Janz M; Schleussner N; Fend F; Pospíšilová Š; Janiková A; Wallwitz J; Stoiber D; Simonitsch-Klupp I; Cerroni L; Pileri S; de Leval L; Sibon D; Fataccioli V; Gaulard P; Assaf C; Knörr F; Damm-Welk C; Woessmann W; Turner SD; Look AT; Mathas S; Kenner L; Merkel O
Nat Commun; 2021 Sep; 12(1):5577. PubMed ID: 34552066
[TBL] [Abstract] [Full Text] [Related]
10. Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple-Negative Subtype of breast cancer Patients.
Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
J Immunol Res; 2020; 2020():5618786. PubMed ID: 33457427
[TBL] [Abstract] [Full Text] [Related]
11. Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors.
Brotherton-Pleiss C; Yue P; Zhu Y; Nakamura K; Chen W; Fu W; Kubota C; Chen J; Alonso-Valenteen F; Mikhael S; Medina-Kauwe L; Tius MA; Lopez-Tapia F; Turkson J
J Med Chem; 2021 Jan; 64(1):695-710. PubMed ID: 33352047
[TBL] [Abstract] [Full Text] [Related]
12. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.
Zhao Q; Bi Y; Zhong J; Li X; Guo J; Liu YX; Pan LR; Tan Y; Deng ZS; Yu XJ
Acta Pharmacol Sin; 2021 May; 42(5):791-800. PubMed ID: 32868906
[TBL] [Abstract] [Full Text] [Related]
13. Identification of an AP1-ZFP36 Regulatory Network Associated with breast cancer Prognosis.
Canzoneri R; Naipauer J; Stedile M; Rodriguez Peña A; Lacunza E; Gandini NA; Curino AC; Facchinetti MM; Coso OA; Kordon E; Abba MC
J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):163-172. PubMed ID: 32248342
[TBL] [Abstract] [Full Text] [Related]
14. STAT3 expression is correlated with pathological stage in luminal subtypes of breast carcinoma.
Eroglu M; Kokenek-Unal TD; Akin-Bali DF; Kirimlioglu SH
Bratisl Lek Listy; 2020; 121(1):51-61. PubMed ID: 31950840
[TBL] [Abstract] [Full Text] [Related]
15. Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting stat5 and STAT6.
Jiang L; Zhao XH; Mao YL; Wang JF; Zheng HJ; You QS
J Exp Clin Cancer Res; 2019 Nov; 38(1):465. PubMed ID: 31718693
[TBL] [Abstract] [Full Text] [Related]
16. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy.
Shaw V; Srivastava S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():75-83. PubMed ID: 31618686
[TBL] [Abstract] [Full Text] [Related]
17. Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-stat5 in precancerous lesions.
Johnston AN; Bu W; Hein S; Garcia S; Camacho L; Xue L; Qin L; Nagi C; Hilsenbeck SG; Kapali J; Podsypanina K; Nangia J; Li Y
Breast Cancer Res; 2018 May; 20(1):42. PubMed ID: 29778097
[TBL] [Abstract] [Full Text] [Related]
18. Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.
Mapes J; Anandan L; Li Q; Neff A; Clevenger CV; Bagchi IC; Bagchi MK
J Biol Chem; 2018 Feb; 293(8):2850-2864. PubMed ID: 29321207
[TBL] [Abstract] [Full Text] [Related]
19. ATM Is Required for the Prolactin-Induced HSP90-Mediated Increase in Cellular Viability and Clonogenic Growth After DNA Damage.
Karayazi Atici Ö; Urbanska A; Gopinathan SG; Boutillon F; Goffin V; Shemanko CS
Endocrinology; 2018 Feb; 159(2):907-930. PubMed ID: 29186352
[TBL] [Abstract] [Full Text] [Related]
20. Identification of new shikonin derivatives as STAT3 inhibitors.
Qiu HY; Fu JY; Yang MK; Han HW; Wang PF; Zhang YH; Lin HY; Tang CY; Qi JL; Yang RW; Wang XM; Zhu HL; Yang YH
Biochem Pharmacol; 2017 Dec; 146():74-86. PubMed ID: 29066190
[TBL] [Abstract] [Full Text] [Related]
[Next]
